DTNEXT Daily Thanthi Thanthi TV

Begin typing your search...

Showing results for "#Novo Nordisk"

Obesity drugmaker Novo Nordisks Q1 profit beats forecast

Obesity drugmaker Novo Nordisk's Q1 profit beats forecast

Novo's growth on the back of the phenomenal success of Wegovy has nonetheless been held back by its ability to meet runaway demand for the weekly...

Diabetes drug Ozempic can reduce severe liver disease risk too

Diabetes drug Ozempic can reduce severe liver disease risk too

Novo Nordisks obesity drug can reduce heart problem risk by 20%

Novo Nordisk's obesity drug can reduce heart problem risk by 20%

Wegovys heart benefits due to more than weight loss, Novo says

Wegovy's heart benefits due to more than weight loss, Novo says

Anti-obesity drug makers face lawsuit in US over ‘stomach paralysis’

Anti-obesity drug makers face lawsuit in US over ‘stomach paralysis’

Intuitive says bariatric surgeries shrink as obesity drugs lift off

Intuitive says bariatric surgeries shrink as obesity drugs lift off

"The only number that investors seem to care about is procedure growth, which slowed to 22% in 2Q," Evercore ISI analyst Vijay Kumar said in a note.